-
-
-
-
-
-
-
Cadrenal Therapeutics, Inc. (CVKD) Tops Q1 EPS by 31c
-
-
-
-
-
-
-
Cadrenal's Quiet Expansion Play Is Starting to Get Loud
-
-
-
-
-
-
-
Cadrenal Therapeutics (CVKD) Announces Tecarfarin Manufacturing Progress in Support of Clinical Trial Readiness
-
-
-
-
-
-
-
Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing
-
-
479,580 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


